PeptideStack
5.2kquestions
20kanswers
220users

Is early satiety on a GLP-1 receptor agonist dose-dependent or dose-rate dependent?

Asked 25 Jul 2025Modified 12 months agoViewed 23k times
31

Setup, so nobody has to ask: early satiety · a GLP-1 receptor agonist.

The empirical answer seems settled. The explanation does not.

If the honest answer is that nobody knows, I would rather hear that than a plausible story.

What is the causal chain, and where does it stop being established?

gi-side-effects
gi-side-effects

The gastrointestinal cluster as a whole - nausea, vomiting, diarrhoea, constipation, reflux, early satiety - with trial incidence rates, dropout…

162 questionstitration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
shareeditfollowflag
IP
askedivo_paunovic16k2725 Jul 2025
7Same situation here, so I will follow this one. – Dr_Ravi_Selvarajah 4 days ago
6How long since the last dose increase? The timing is most of the diagnosis here. – ivo_paunovic 8 months ago
add a comment

No answers yet

This question has not been answered. It has been viewed 23k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.